MarketPeel
Insider Trading Intelligence
Pricing
…
FY

Frank Yocca

BTAI
CHIEF SCIENTIFIC OFFICER · BIOXCEL THERAPEUTICS, INC. · CIK 0001733272
FILING MIX · LIFETIME44%/56%
BUYS
39
SELLS
49
TOTAL VALUE
$3.89M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
212
AVG SELL PX
$34.33
TRADE KIND
SHOWING 88 / 88
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
20 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Frank Yocca, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d20+70.00%-3.23%-0.80%-2.43%-1.54%—
14d20+75.00%-2.70%-0.09%-2.61%-5.21%—
30d20+75.00%-10.09%+1.27%-11.35%-12.95%—
60d20+95.00%-31.41%+4.47%-35.89%-42.83%—
90d20+95.00%-38.95%+5.95%-44.89%-51.29%—
180d20+100.00%-60.33%+12.15%-72.48%-72.47%—
1y20+100.00%-72.36%+14.78%-87.14%-82.63%—
2y20(3 pending)+100.00%-56.25%+14.82%-71.08%-49.53%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BTAI · 212 shares · as of Jun 15, 2026
067,500135,000202,500270,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 39 buys / 49 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
35——212Jun 15, 2026Jun 17, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
35——26,210Jun 15, 2026Jun 17, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,845$1.09$7.4K26,175May 20, 2026May 22, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
17,500——33,020May 4, 2026May 22, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
17,500——52,500May 4, 2026May 22, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
9,000——0May 1, 2026May 7, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
9,000——15,520May 1, 2026May 7, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
35——6,520Mar 15, 2026Mar 16, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
35——247Mar 15, 2026Mar 16, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
33——97Mar 14, 2026Mar 16, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
33——6,485Mar 14, 2026Mar 16, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
70,000——70,282Jan 1, 2026Jan 5, 2026 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
35——282Dec 15, 2025Dec 15, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
35——6,452Dec 15, 2025Dec 15, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
33——6,417Dec 14, 2025Dec 15, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
33——130Dec 14, 2025Dec 15, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
35——6,384Sep 15, 2025Sep 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
35——317Sep 15, 2025Sep 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
33——163Sep 14, 2025Sep 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
33——6,349Sep 14, 2025Sep 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,000——9,000Aug 1, 2025Aug 5, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,375——6,316Jul 22, 2025Jul 22, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
35——352Jun 15, 2025Jun 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
35——1,941Jun 15, 2025Jun 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
33——1,906Jun 14, 2025Jun 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
33——196Jun 14, 2025Jun 16, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
34——1,873Mar 15, 2025Mar 17, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
34——387Mar 15, 2025Mar 17, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
31——229Mar 14, 2025Mar 17, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
31——1,839Mar 14, 2025Mar 17, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
270,000——270,000Jan 7, 2025Jan 10, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
205$0.36$7329,156Dec 16, 2024Dec 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
225$0.35$7928,931Dec 16, 2024Dec 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
562——5,064Dec 15, 2024Dec 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
562——29,361Dec 15, 2024Dec 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
521——2,606Dec 14, 2024Dec 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
521——28,799Dec 14, 2024Dec 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,175$0.55$3.9K28,278Oct 3, 2024Oct 3, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
21,250——35,453Sep 17, 2024Oct 3, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
355$0.69$24514,203Sep 16, 2024Sep 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
563——5,625Sep 15, 2024Sep 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
563——14,558Sep 15, 2024Sep 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
521——13,995Sep 14, 2024Sep 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
521——3,127Sep 14, 2024Sep 17, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,875——1,875Jul 22, 2024Apr 1, 2025 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
372$1.28$47613,474Jun 17, 2024Jun 18, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
562——13,846Jun 15, 2024Jun 18, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
562——6,188Jun 15, 2024Jun 18, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
521——3,648Jun 14, 2024Jun 18, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
521——13,284Jun 14, 2024Jun 18, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,067$2.64$2.8K12,763Apr 4, 2024Apr 8, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,250——13,830Mar 15, 2024Apr 8, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,250——6,750Mar 15, 2024Apr 8, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
521——4,169Mar 14, 2024Apr 8, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
521——11,580Mar 14, 2024Apr 8, 2024 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
521——11,059Dec 14, 2023Dec 18, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
521——4,690Dec 14, 2023Dec 18, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
521——10,538Sep 14, 2023Sep 18, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
521——5,211Sep 14, 2023Sep 18, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
521——10,017Jun 14, 2023Jun 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
521——5,732Jun 14, 2023Jun 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,000——9,000Mar 15, 2023Mar 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
32,000——32,000Mar 15, 2023Mar 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
985$19.69$19.4K9,496Mar 15, 2023Mar 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,084——10,481Mar 14, 2023Mar 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,084——6,253Mar 14, 2023Mar 16, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
50,000$30.00$1.50M8,397Jan 20, 2023Jan 24, 2023 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
33,350——33,350Mar 14, 2022Mar 16, 2022 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,337——8,337Mar 14, 2022Mar 16, 2022 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,000——22,000Mar 25, 2021Mar 29, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
630$49.30$31.1K58,397Mar 15, 2021Mar 17, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
14,370$48.47$696.5K59,027Mar 15, 2021Mar 17, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
500$59.46$29.7K75,769Feb 16, 2021Feb 18, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,300$55.88$72.6K87,097Feb 16, 2021Feb 18, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
600$61.20$36.7K73,397Feb 16, 2021Feb 18, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,137$57.71$65.6K79,155Feb 16, 2021Feb 18, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
6,805$56.49$384.4K80,292Feb 16, 2021Feb 18, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,886$58.54$168.9K76,269Feb 16, 2021Feb 18, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,772$60.43$107.1K73,997Feb 16, 2021Feb 18, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
4,107$49.35$202.7K88,397Jan 25, 2021Jan 27, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
15,000$0.41$6.2K103,397Jan 25, 2021Jan 27, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
15,000——54,310Jan 25, 2021Jan 27, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
6,521$48.39$315.6K92,504Jan 25, 2021Jan 27, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
900$46.94$42.2K102,497Jan 25, 2021Jan 27, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,472$47.62$165.3K99,025Jan 25, 2021Jan 27, 2021 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
45,000——45,000May 26, 2020May 28, 2020 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
Chief Scientific Officer
80,000——69,310Feb 14, 2020Feb 19, 2020 ↗View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
80,000$0.41$32.8K88,397Feb 14, 2020Feb 19, 2020 ↗View →
Other insiders · BTAI
Loading peer insiders…
About this filer
CIK 0001733272
ROLE
Chief Scientific Officer
PRIMARY
BTAI
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001733272DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback